tafenoquine has been researched along with Eye Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beboso, R; Bi, D; Brater, DC; Cantilena, LR; Kerr, C; Leary, KJ; Ohrt, C; Pruett, K; Riel, MA; Roy, MJ; van de Pol, C; Veazey, JM | 1 |
1 trial(s) available for tafenoquine and Eye Disorders
| Article | Year |
|---|---|
A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Double-Blind Method; Eye Diseases; Female; Humans; Kidney Diseases; Male; Middle Aged; Night Vision; Young Adult | 2009 |